BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36463449)

  • 1. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.
    Shirgadwar SM; Kumar R; Preeti K; Khatri DK; Singh SB
    J Alzheimers Dis; 2023; 94(s1):S109-S124. PubMed ID: 36463449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1/Nrf2 signaling pathway.
    Pan PK; Qiao LY; Wen XN
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):11-17. PubMed ID: 28145852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection of Andrographolide against Neurotoxin MPP
    Prasertsuksri P; Kraokaew P; Pranweerapaiboon K; Sobhon P; Chaithirayanon K
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geniposide protects against neurotoxicity in mouse models of rotenone-induced Parkinson's disease involving the mTOR and Nrf2 pathways.
    Zhou Q; Chen B; Xu Y; Wang Y; He Z; Cai X; Qin Y; Ye J; Yang Y; Shen J; Cao P
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116914. PubMed ID: 37451492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways.
    Zhou Q; Chen B; Wang X; Wu L; Yang Y; Cheng X; Hu Z; Cai X; Yang J; Sun X; Lu W; Yan H; Chen J; Ye J; Shen J; Cao P
    Sci Rep; 2016 Aug; 6():32206. PubMed ID: 27553905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1α,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson's Disease.
    de Siqueira EA; Magalhães EP; de Assis ALC; Sampaio TL; Lima DB; Marinho MM; Martins AMC; de Andrade GM; de Barros Viana GS
    Neurochem Res; 2023 Jan; 48(1):250-262. PubMed ID: 36066698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel trajectories of the NK1R antagonist aprepitant in rotenone-induced Parkinsonism-like symptoms in rats: Involvement of ERK5/KLF4/p62/Nrf2 signaling axis.
    El-Deeb AM; Mohamed AF; El-Yamany MF; El-Tanbouly DM
    Chem Biol Interact; 2023 Aug; 380():110562. PubMed ID: 37224993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling.
    El-Sayed RM; Abdelaziz AM; Zaki HF; Abdel Rasheed NO
    Int Immunopharmacol; 2023 Apr; 117():109986. PubMed ID: 37012873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy.
    Azimullah S; Jayaraj RL; Meeran MFN; Jalal FY; Adem A; Ojha S; Beiram R
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Diacetylcurcumin Manganese Complex on Rotenone-Induced Oxidative Stress, Mitochondria Dysfunction, and Inflammation in the SH-SY5Y Parkinson's Disease Cell Model.
    Pirunkaset E; Boonyarat C; Maneenet J; Khamphukdee C; Daodee S; Monthakantirat O; Awale S; Kijjoa A; Chulikhit Y
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroprotective effect of ginsenoside Re on drosophila model of Parkinson's disease].
    Xu Y; Meng X; Zhao WX; Liu DG; Zhu JG; Yao R; Yao JC; Zhang GM
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1927-1935. PubMed ID: 37282969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.
    Michel HE; Tadros MG; Esmat A; Khalifa AE; Abdel-Tawab AM
    Mol Neurobiol; 2017 Sep; 54(7):4866-4878. PubMed ID: 27514753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
    Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
    Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
    Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
    Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Atg7-dependent autophagy by a novel inhibitor of the Keap1-Nrf2 protein-protein interaction from
    Sun Y; He L; Wang W; Xie Z; Zhang X; Wang P; Wang L; Yan C; Liu Z; Zhao J; Cui Z; Wang Y; Tang L; Zhang Z
    Food Funct; 2022 Jul; 13(14):7885-7900. PubMed ID: 35776077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats.
    Habib CN; Mohamed MR; Tadros MG; Tolba MF; Menze ET; Masoud SI
    Eur J Pharmacol; 2022 Jan; 914():174573. PubMed ID: 34656609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways.
    Jayaraj RL; Beiram R; Azimullah S; Mf NM; Ojha SK; Adem A; Jalal FY
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRUP-1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson's disease model.
    Kataura T; Saiki S; Ishikawa KI; Akamatsu W; Sasazawa Y; Hattori N; Imoto M
    J Neurochem; 2020 Oct; 155(1):81-97. PubMed ID: 32128811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin Modulates p62-Keap1-Nrf2-Mediated Autophagy in Rotenone-Induced Parkinson's Disease Mouse Models.
    Rathore AS; Singh SS; Birla H; Zahra W; Keshri PK; Dilnashin H; Singh R; Singh S; Singh SP
    ACS Chem Neurosci; 2023 Mar; ():. PubMed ID: 36989171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/HO-1 signaling.
    Lu Q; Gouda NA; Quan G; Nada H; Elkamhawy A; Lee D; Lee CH; Cho J; Lee K
    Eur J Med Chem; 2022 Nov; 242():114692. PubMed ID: 36029560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.